Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Type 2 Diabetes
Interventions: Meal timing, Time restricted eating, Usual feeding pattern.; Other
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 75 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Pain
Interventions: transcranial alternating current stimulation (tACS), Sham, transcranial random noise stimulation (tRNS); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chemotherapy Effect, Chemotherapeutic Toxicity, Fasting
Interventions: FMD; Dietary Supplement
Lead sponsor: Sutter Health; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Fever
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Major Depressive Disorder
Interventions: Standard Clinical Care with an SSRI; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 60 Years
Enrollment: 228 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Schizophrenia, Negative Type; Schizophrenic, Schizo Affective Disorder
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus
Interventions: VGo; Device
Lead sponsor: East Coast Institute for Research; Network
Eligibility: 21 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Jacksonville, Florida • Macon, Georgia

Conditions: Oropharyngeal Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions: Standard Radiation Treatment, Dose-Deescalated Treatment, Cisplatinum; Radiation · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Cellular Injury and Post-Cryogenic Recovery, Cryogenic Cellular Stress, Cold-Induced Cellular Injury, Thermal Injury Response, Post-Thaw Viability Impairment, Osmotic Stress Injury, Biomechanical Injury Modeling (In-Vitro), Blunt Force Injuries to the Extremities (Cellular Injury Model), Tissue Damage and Recovery Pathways, Hypothermic Tissue Stress, Cellular Regeneration and Repair
Interventions: Standard Laboratory Cryopreservation Procedure, Enhanced Laboratory Cryopreservation Procedure, Normothermic Cell Culture Control; Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2066
U.S. locations: 1
States / cities: New York, New York

Conditions: Maternity, Pregnancy, Labor and Delivery, Hemodynamic Changes
Interventions: ClearSight™ System, Transthoracic Echocardiography, Passive Leg Raising (PLR) Maneuver; Device · Procedure
Lead sponsor: Ayse Zeynep Turan Civraz; Government
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cystic Fibrosis
Interventions: FDG-PET; Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years to 21 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: COVID-19, Respiratory Viral Infection, Infections, Respiratory
Interventions: ADVANCE Steering Committee interventions; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 37,122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Schwenksville, Pennsylvania

Conditions: Type 2 Diabetes
Interventions: Control-IQ use in Type 2 Diabetes under basal insulin injections; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)
Interventions: Cyclophosphamide, Fludarabine, Thiotepa, Melphalan, G-csf, Mesna, CliniMACS, ATG (rabbit), Blinatumomab, TCRα/β+, CD19+, CD45RA-depleted DLI; Drug · Biological · Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Cerebrovascular Accident
Interventions: Magnesium Sulfate, Normal Saline; Drug
Lead sponsor: Jeffrey L. Saver; Other
Eligibility: 40 Years to 95 Years
Enrollment: 1,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Healthy
Interventions: Exercise; Other
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Prostatic Hyperplasia
Interventions: Treatment sequence A, Treatment sequence B, Treatment sequence C; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anxiety and Fear, Pain
Interventions: STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents; Other
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 18 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Syphilis Infection
Interventions: Rapid Syphilis Test; Diagnostic Test
Lead sponsor: Queen's Medical Center; Other
Eligibility: 14 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: CNS Malignancies, Medulloblastoma Recurrent, ATRT Recurrent, Pineoblastoma, Embryonal Neoplasm, Ependymoma Recurrent, High Grade Gliomas
Interventions: SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab; Drug · Radiation
Lead sponsor: Children's National Research Institute; Other
Eligibility: 3 Years to 21 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Knee Arthritis, Hip Arthritis
Interventions: Wagner Pain Algometer, Dynamometer; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Postoperative Wound Infection, Traumatic Wound Infection, Closed Soft Tissue Abscess
Interventions: Not listed
Lead sponsor: Brentwood Biomedical Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Los Angeles, California • Sylmar, California

Conditions: Anxiety, Stress, Mood, Motivation, Well-Being, Psychological, Self Esteem
Interventions: Rapid Planning Method (RPM), Journaling; Behavioral
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 19 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

The Impact of Time Restricted Eating on Type 2 Diabetes

High Risk Screening Breast MR Using a Rapid Imaging Exam

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Can Fasting Decrease the Side Effects of Chemotherapy?

Quantifying and Understanding the Signs and Symptoms of Fever

Cellular Aging and Neurobiology of Depression Study

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

Regular Insulin vs Rapid Insulin Delivered by V-Go

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001)

Passive Leg Raising in Term Pregnancy on Hemodynamic Monitoring - Validating With Transthoracic ECHO (LG-ECHO)

FDG-PET Imaging in Young Cystic Fibrosis Patients

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial

T Cell Responses to Various Levels of Exercise Stress

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States

Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Preoperative Pain Threshold and Rapid Recover Programs

Rapid Identification of Key Pathogens in Wound Infection by Molecular Means

Efficacy of the Tony Robbins Rapid Planning Method (RPM)